INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
REPORT OUTLOOK
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 99.75 billion by 2029 | 8.2% | North America |
| By Device Type | By Application | By End User |
|---|---|---|
|
|
|
SCOPE OF THE REPORT
Cardiovascular Devices Market Overview:
The Global Cardiovascular Devices Market is projected to grow from USD 50.76 billion in 2020 to USD 99.75 billion by 2029, at a CAGR of 8.2% during the forecast period.
The cardiovascular devices market refers to the global market for medical devices that are specifically designed for the diagnosis, treatment, and management of cardiovascular diseases (CVDs). These devices play a crucial role in providing effective healthcare solutions for various cardiovascular conditions, including coronary artery disease, heart failure, arrhythmias, and peripheral vascular diseases.
The market for cardiovascular devices is driven by several factors, including the increasing prevalence of cardiovascular diseases worldwide. CVDs are a leading cause of morbidity and mortality globally, and the growing aging population, sedentary lifestyle, unhealthy dietary habits, and rising prevalence of risk factors such as obesity, diabetes, and hypertension contribute to the increasing burden of cardiovascular diseases.
Technological advancements in cardiovascular devices have also fueled market growth. Innovations in areas such as interventional cardiology, cardiac rhythm management, cardiac monitoring, and peripheral vascular interventions have improved patient outcomes and expanded treatment options. Examples of cardiovascular devices include stents, catheters, pacemakers, defibrillators, heart valves, and diagnostic imaging systems.
Government initiatives, favorable reimbursement policies, and increased healthcare spending have also contributed to market growth. Additionally, the rising demand for minimally invasive procedures, advancements in robotic-assisted surgeries, and the integration of digital health technologies in cardiovascular devices are expected to drive market growth in the coming years.
The global cardiovascular devices market is experiencing significant growth due to the increasing prevalence of cardiovascular diseases and technological advancements. The market is highly competitive, with a wide range of devices and players catering to the needs of patients and healthcare providers. Continued innovation, improved patient outcomes, and favorable market dynamics are expected to drive the growth of the cardiovascular devices market in the foreseeable future.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2029 |
| Base year | 2021 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD Billion), (Thousand Units) |
| Segmentation | By Device Type, by Application, by End User, and by Region.  |
| By Device Type |
|
| By Application |
|
| By End User |
|
| By Region |
|
Segmentation Analysis:
The global cardiovascular devices market is segmented based on Device type, application, end-user, and region. By device type, the market is bifurcated into  Cardiac Rhythm Management Devices, Interventional Cardiology Devices, Cardiovascular Surgery Devices, Diagnostic and Monitoring Devices, and Peripheral Vascular Devices. By application the market is bifurcated into Coronary Artery Disease (CAD), Heart Failure, Arrhythmias, Peripheral Artery Disease (PAD), Others (Valvular Heart Disease, Congenital Heart Defects, etc.). by end-user market is bifurcated into Hospitals and Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Cardiac Catheterization Laboratories, Others (Research Institutes, Homecare Settings, etc.)
Based on device type cardiovascular surgery devices segment is dominating the cardiovascular devices. Cardiovascular diseases, including coronary artery disease, heart failure, and arrhythmias, are among the leading causes of mortality worldwide. Surgical interventions are often required to treat these conditions, leading to significant demand for cardiovascular surgery devices. Cardiovascular surgery devices encompass a wide range of products used in various surgical procedures, including coronary artery bypass grafting (CABG), heart valve replacement, aortic aneurysm repair, and more. The diverse array of procedures contributes to the segment’s dominance. Cardiovascular surgeons are highly specialized medical professionals who require specific tools and devices to perform intricate procedures. The availability of these devices supports the growth of the cardiovascular surgery devices segment.
The aging global population is more susceptible to cardiovascular diseases, and surgical interventions become more common as individuals age. This demographic trend increases the demand for cardiovascular surgery devices. Many surgical procedures involving cardiovascular surgery devices are covered by health insurance, making them accessible to a larger patient population and contributing to market demand.
Based on end-user hospitals and clinics centers segment dominating the cardiovascular devices market. Cardiovascular procedures, especially surgeries, and interventions, often require specialized medical facilities with advanced infrastructure, equipment, and skilled healthcare professionals. Hospitals and clinics are well-equipped to handle complex cardiovascular procedures, making them a central hub for cardiovascular device usage. Cardiovascular surgeries and interventions require the expertise of highly trained cardiovascular surgeons, interventional cardiologists, and other specialized healthcare professionals. Hospitals and clinics are staffed with these professionals who are trained to perform intricate procedures using cardiovascular devices.
Hospitals and clinics use advanced imaging techniques such as angiography, echocardiography, and cardiac MRI to diagnose cardiovascular conditions. These diagnostic tools rely on specialized devices and equipment, driving the demand for imaging-related cardiovascular devices. High-quality hospitals and clinics attract patients from different regions seeking specialized cardiovascular care. This influx of patients contributes to the increased utilization of cardiovascular devices. Hospitals and clinics are at the forefront of adopting new technologies and devices that enhance patient outcomes. Their willingness to embrace innovative solutions drives the adoption of advanced cardiovascular devices.
Competitive Landscape:
The competitive environment for cardiovascular devices has been built up of a mix of well-known medical device companies, cutting-edge startups, and research-oriented universities. These companies compete with one another in the cardiovascular devices industry across a variety of verticals, including cardiac rhythm management, interventional devices, diagnostic and imaging tools, and more.
Here are some of the key aspects of the competitive landscape in the cardiovascular devices market:
- Medtronic
- Abbott Laboratories
- Boston Scientific
- Edwards Lifesciences
- Johnson & Johnson
- Philips Healthcare
- Siemens Healthineers
- GE Healthcare
- Biotronik
- Terumo Corporation
- Stryker Corporation
- LivaNova
- MicroPort Scientific Corporation
- Penumbra, Inc.
- L. Gore & Associates
- Teleflex Incorporated
- BD (Becton, Dickinson, and Company)
- Getinge AB
- Abiomed
- Cardinal Health
These are the top 20 key players who play an important role in the Cardiovascular Devices market.
Market Dynamics:
Driver:
Increasing demand for interventional procedures drives the cardiovascular device market growth.
Interventional procedures are often minimally invasive, involving small incisions or catheter-based approaches. Patients benefit from shorter hospital stays, reduced pain, faster recovery, and fewer complications compared to open surgeries. The global prevalence of cardiovascular diseases, including coronary artery disease, heart valve disorders, and peripheral vascular conditions, has led to an increased demand for effective treatment options. Interventional procedures offer viable solutions for a wide range of cardiovascular conditions. Technological advancements have led to the development of innovative and sophisticated cardiovascular devices, such as stents, angioplasty balloons, atherectomy devices, and catheters. These devices enable physicians to perform complex interventions with greater precision and success rates. Interventional procedures can be tailored to individual patient needs, considering factors such as disease severity, anatomical variations, and overall health status.
The field of interventional cardiology is characterized by ongoing innovation, with manufacturers continuously developing new and improved devices to enhance procedural outcomes and patient care.
Restraint:
 The high cost of devices hampers the cardiovascular device market growth.
High device costs can create barriers to access for patients, especially those with limited financial means or without adequate insurance coverage. This limitation prevents a portion of the patient population from receiving necessary cardiovascular treatments and interventions. Healthcare systems and hospitals may struggle to manage the financial burden of acquiring and maintaining expensive cardiovascular devices. This strain can lead to budgetary constraints and impact investment in new technologies. High device costs can discourage healthcare providers from adopting new and innovative technologies, as they weigh the perceived benefits against the financial implications. This can slow down the integration of cutting-edge devices into clinical practice. High device costs can result in substantial out-of-pocket expenses for patients, even after insurance coverage. This financial burden on patients can lead to reluctance in pursuing necessary treatments. The overall growth of the cardiovascular device market can be limited when high costs deter widespread adoption, preventing the market from reaching its full potential.
Opportunities:
The rise of telemedicine and remote monitoring technologies creates opportunities in the cardiovascular devices market.
Telemedicine allows healthcare providers to remotely monitor patients with cardiovascular conditions, reducing the need for frequent in-person visits. Patients can use wearable devices and sensors to track vital signs, such as heart rate, blood pressure, and ECG data, which can be transmitted to healthcare professionals for real-time monitoring. Remote monitoring enables early detection of changes in a patient’s condition, allowing healthcare providers to intervene promptly. This can prevent exacerbation of cardiovascular issues and reduce the risk of complications. Timely intervention based on remote monitoring data can lead to a reduction in hospitalizations and emergency room visits, resulting in cost savings for both patients and healthcare systems. The collection of real-time patient data through remote monitoring generates valuable insights for healthcare providers and researchers. Analyzing this data can lead to a better understanding of cardiovascular diseases and more targeted treatment approaches.
The integration of telemedicine and remote monitoring technologies with cardiovascular devices stimulates innovation in device design and functionality, leading to the development of more advanced and user-friendly products. These are some factors that create opportunities in the cardiovascular devices market.
Challenges:
Risk of complications and adverse events This factor creates challenges for the cardiovascular device market.
Complications and adverse events, such as infections, device failures, or tissue damage, can jeopardize patient safety and well-being. Patient harm from these events can lead to serious health consequences and legal implications for manufacturers and healthcare providers. Physicians may be hesitant to adopt or recommend certain cardiovascular devices if they perceive a higher risk of complications or adverse events. This reluctance can slow down the adoption of new technologies and limit patient access to potentially beneficial devices. Regulatory agencies closely monitor the safety and performance of cardiovascular devices. Instances of complications or adverse events can lead to increased regulatory scrutiny, potential recalls, and more stringent approval processes, affecting market access and product development timelines. Manufacturers and healthcare providers may face legal challenges and liability claims in the event of complications or adverse events. Legal proceedings can result in financial burdens, reputational damage, and resource allocation away from innovation and growth efforts
Market Trends:
- There has been a growing trend towards minimally invasive procedures in the field of cardiovascular interventions. Advances in catheter-based techniques and technologies have led to an increased preference for procedures such as transcatheter aortic valve replacement (TAVR), percutaneous coronary interventions (PCI), and endovascular interventions.
- Advances in genomics and biomarker research are driving a trend toward personalized and precision medicine in cardiovascular care. Devices and treatments are increasingly tailored to individual patient characteristics, leading to more effective and targeted interventions.
- There is a growing focus on structural heart interventions, including transcatheter valve replacements and repairs. These interventions offer less invasive alternatives to traditional open-heart surgeries.
- Patient-centered design principles are being applied to the development of cardiovascular devices, ensuring that devices are not only effective but also user-friendly and aligned with patient preferences.
- There is a growing emphasis on developing cardiovascular devices with reduced environmental impact, including considerations for sustainable materials and recycling.
Regional Analysis:
North America accounted for the largest market in the cardiovascular devices market. North America accounted for 39 % market share of the global market value. North America has a relatively high incidence of cardiovascular diseases, including conditions like coronary artery disease, hypertension, and heart failure. This creates a substantial demand for cardiovascular devices and treatments.  The region’s advanced healthcare infrastructure, including well-equipped hospitals, specialized clinics, and a skilled workforce, supports the adoption of a wide range of cardiovascular devices and procedures. North America is a hub for medical technology innovation, with many leading manufacturers and research institutions based in the United States and Canada. This fosters the development and adoption of cutting-edge cardiovascular devices.
North America has a skilled and experienced medical workforce, including cardiologists, surgeons, and interventionists, who are proficient in using and integrating cardiovascular devices into patient care. Public awareness campaigns and health education initiatives contribute to the early diagnosis and treatment of cardiovascular diseases, driving demand for related devices. These are some factors that help to propel the market growth in the North American region.
Import & Export Data for Cardiovascular Devices Market:
Exactitude consultancy provides import and export data for the recent years. It also offers insights on production and consumption volume of the product. Understanding the import and export data is pivotal for any player in the Cardiovascular Devices Market. This knowledge equips businesses with strategic advantages, such as:
- Identifying emerging markets with untapped potential.
- Adapting supply chain strategies to optimize cost-efficiency and market responsiveness.
- Navigating competition by assessing major players’ trade dynamics.
Key Insights:
- Trade Volume Trends: Our report dissects import and export data spanning the last five years to reveal crucial trends and growth patterns within the global Cardiovascular Devices Market. This data-driven exploration empowers readers with a deep understanding of the market’s trajectory.
- Market Players:Â Gain insights into the leading players driving the air brake system trade. From established giants to emerging contenders, our analysis highlights the key contributors to the import and export landscape.
- Geographical Dynamics: Delve into the geographical distribution of trade activities. Uncover which regions dominate exports and which ones hold the reins on imports, painting a comprehensive picture of the industry’s global footprint.
- Product Breakdown: By segmenting data based on air brake system types – DRAM, NAND, and more – we provide a granular view of trade preferences and shifts, enabling businesses to align strategies with the evolving technological landscape.
Import and export data is crucial in reports as it offers insights into global market trends, identifies emerging opportunities, and informs supply chain management. By analyzing trade flows, businesses can make informed decisions, manage risks, and tailor strategies to changing demand. This data aids governments in policy formulation and trade negotiations, while investors use it to assess market potential. Moreover, import and export data contributes to economic indicators, influences product innovation, and promotes transparency in international trade, making it an essential component for comprehensive and informed analyses.
Key Question Answered:
- What is the expected growth rate of the cardiovascular devices market over the next 7 years?
- Who are the major players in the cardiovascular devices market and what is their market share?
- What are the end-user industries driving market demand and what is their outlook?
- What are the opportunities for growth in emerging markets such as Asia-pacific, the middle east, and Africa?
- How is the economic environment affecting the cardiovascular devices market, including factors such as interest rates, inflation, and exchange rates?
- What is the expected impact of government policies and regulations on the cardiovascular devices market?
- What is the current and forecasted size and growth rate of the global cardiovascular devices market?
- What are the key drivers of growth in the cardiovascular devices market?
- Who are the major players in the market and what is their market share?
- What are the distribution channels and supply chain dynamics in the cardiovascular devices market?
- What are the technological advancements and innovations in the cardiovascular devices market and their impact on product development and growth?
- What are the regulatory considerations and their impact on the market?
- What are the challenges faced by players in the cardiovascular devices market and how are they addressing these challenges?
- What are the opportunities for growth and expansion in the cardiovascular devices market?
- What are the product offerings and specifications of leading players in the market?
Table of Content
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- CARDIOVASCULAR DEVICES MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON THE CARDIOVASCULAR DEVICES MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- CARDIOVASCULAR DEVICES MARKET OUTLOOK
- GLOBAL CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE, 2020-2029, (USD BILLION), (THOUSAND UNITS)
- CARDIAC RHYTHM MANAGEMENT DEVICES
- PACEMAKERS
- IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS)
- CARDIAC RESYNCHRONIZATION THERAPY DEVICES (CRT)
- EXTERNAL DEFIBRILLATORS
- INTERVENTIONAL CARDIOLOGY DEVICES
- CORONARY STENTS
- CATHETERS
- BALLOON VALVULOPLASTY DEVICES
- ANGIOPLASTY DEVICES
- ATHERECTOMY DEVICES
- EMBOLIC PROTECTION DEVICES
- CARDIOVASCULAR SURGERY DEVICES
- HEART VALVES (MECHANICAL, BIOLOGICAL)
- CARDIAC ASSIST DEVICES
- CARDIOPULMONARY BYPASS EQUIPMENT
- VENTRICULAR ASSIST DEVICES (VADS)
- HEART-LUNG MACHINES
- DIAGNOSTIC AND MONITORING DEVICES
- ELECTROCARDIOGRAPHY (ECG) DEVICES
- ECHOCARDIOGRAPHY DEVICES
- HOLTER MONITORS
- CARDIAC EVENT MONITORS
- CARDIAC MRI AND CT SCANNERS
- DOPPLER FETAL MONITORS
- PERIPHERAL VASCULAR DEVICES
- PERIPHERAL VASCULAR STENTS
- PERIPHERAL CATHETERS
- PERIPHERAL GUIDEWIRES
- ANGIOGRAPHY BALLOONS
- EMBOLIC PROTECTION DEVICES
- ATHERECTOMY DEVICES
- CARDIAC RHYTHM MANAGEMENT DEVICES
- GLOBAL CARDIOVASCULAR DEVICES MARKET BY APPLICATION, 2020-2029, (USD BILLION), (THOUSAND UNITS)
- CORONARY ARTERY DISEASE (CAD)
- HEART FAILURE
- ARRHYTHMIAS
- PERIPHERAL ARTERY DISEASE (PAD)
- OTHERS (VALVULAR HEART DISEASE, CONGENITAL HEART DEFECTS, ETC.)
- GLOBAL CARDIOVASCULAR DEVICES MARKET BY END-USER, 2020-2029, (USD BILLION), (THOUSAND UNITS)
- HOSPITALS AND CLINICS
- AMBULATORY SURGICAL CENTERS
- DIAGNOSTIC CENTERS
- CARDIAC CATHETERIZATION LABORATORIES
- OTHERS (RESEARCH INSTITUTES, HOMECARE SETTINGS, ETC.)
- GLOBAL CARDIOVASCULAR DEVICES MARKET BY REGION, 2020-2029, (USD BILLION), (THOUSAND UNITS)
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- NORTH AMERICA
- COMPANY PROFILES* (BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
- ITRON INC.
- LANDIS+GYR
- SIEMENS AG
- KAMSTRUP A/S
- HONEYWELL INTERNATIONAL INC.
- ISKRAEMECO
- ELSTER GROUP (OWNED BY HONEYWELL)
- SENSUS (XYLEM INC.)
- JIANGSU LINYANG ELECTRONICS CO., LTD.
- WASION GROUP HOLDINGS LIMITED *THE COMPANY LIST IS INDICATIVE
LIST OF TABLES
TABLE 1Â Â Â Â Â GLOBAL CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 2Â Â Â Â Â GLOBAL CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 3Â Â Â Â Â GLOBAL CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 4Â Â Â Â Â GLOBAL CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 5Â Â Â Â Â GLOBAL CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 6Â Â Â Â Â GLOBAL CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 7Â Â Â Â Â GLOBAL CARDIOVASCULAR DEVICES MARKET BY REGION (USD BILLION) 2020-2029
TABLE 8Â Â Â Â Â GLOBAL CARDIOVASCULAR DEVICES MARKET BY REGION (THOUSAND UNITS) 2020-2029
TABLE 9Â Â Â Â Â NORTH AMERICA CARDIOVASCULAR DEVICES MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 10Â Â Â NORTH AMERICA CARDIOVASCULAR DEVICES MARKET BY COUNTRY (THOUSAND UNITS) 2020-2029
TABLE 11Â Â Â NORTH AMERICA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 12Â Â Â NORTH AMERICA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 13Â Â Â NORTH AMERICA CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 14Â Â Â NORTH AMERICA CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 15Â Â Â NORTH AMERICA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 16Â Â Â NORTH AMERICA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 17Â Â Â US CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 18Â Â Â US CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 19Â Â Â US CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 20Â Â Â US CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 21Â Â Â US CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 22Â Â Â US CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 23Â Â Â CANADA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 24Â Â Â CANADA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 25Â Â Â CANADA CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 26Â Â Â CANADA CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 27Â Â Â CANADA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 28Â Â Â CANADA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 29Â Â Â MEXICO CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 30Â Â Â MEXICO CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 31Â Â Â MEXICO CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 32Â Â Â MEXICO CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 33Â Â Â MEXICO CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 34Â Â Â MEXICO CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 35Â Â Â SOUTH AMERICA CARDIOVASCULAR DEVICES MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 36Â Â Â SOUTH AMERICA CARDIOVASCULAR DEVICES MARKET BY COUNTRY (THOUSAND UNITS) 2020-2029
TABLE 37Â Â Â SOUTH AMERICA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 38Â Â Â SOUTH AMERICA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 39Â Â Â SOUTH AMERICA CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 40Â Â Â SOUTH AMERICA CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 41Â Â Â SOUTH AMERICA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 42Â Â Â SOUTH AMERICA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 43Â Â Â BRAZIL CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 44Â Â Â BRAZIL CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 45Â Â Â BRAZIL CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 46Â Â Â BRAZIL CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 47Â Â Â BRAZIL CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 48Â Â Â BRAZIL CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 49Â Â Â ARGENTINA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 50Â Â Â ARGENTINA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 51Â Â Â ARGENTINA CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 52Â Â Â ARGENTINA CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 53Â Â Â ARGENTINA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 54Â Â Â ARGENTINA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 55Â Â Â COLOMBIA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 56Â Â Â COLOMBIA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 57Â Â Â COLOMBIA CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 58Â Â Â COLOMBIA CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 59Â Â Â COLOMBIA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 60Â Â Â COLOMBIA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 61Â Â Â REST OF SOUTH AMERICA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 62Â Â Â REST OF SOUTH AMERICA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 63Â Â Â REST OF SOUTH AMERICA CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 64Â Â Â REST OF SOUTH AMERICA CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 65Â Â Â REST OF SOUTH AMERICA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 66Â Â Â REST OF SOUTH AMERICA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 67Â Â Â ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 68Â Â Â ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET BY COUNTRY (THOUSAND UNITS) 2020-2029
TABLE 69Â Â Â ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 70Â Â Â ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 71Â Â Â ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 72Â Â Â ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 73Â Â Â ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 74Â Â Â ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 75Â Â Â INDIA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 76Â Â Â INDIA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 77Â Â Â INDIA CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 78Â Â Â INDIA CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 79Â Â Â INDIA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 80Â Â Â INDIA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 81Â Â Â CHINA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 82Â Â Â CHINA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 83Â Â Â CHINA CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 84Â Â Â CHINA CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 85Â Â Â CHINA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 86Â Â Â CHINA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 87Â Â Â JAPAN CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 88Â Â Â JAPAN CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 89Â Â Â JAPAN CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 90Â Â Â JAPAN CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 91Â Â Â JAPAN CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 92Â Â Â JAPAN CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 93Â Â Â SOUTH KOREA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 94Â Â Â SOUTH KOREA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 95Â Â Â SOUTH KOREA CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 96Â Â Â SOUTH KOREA CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 97Â Â Â SOUTH KOREA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 98Â Â Â SOUTH KOREA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 99Â Â Â AUSTRALIA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 100Â AUSTRALIA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 101Â AUSTRALIA CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 102Â AUSTRALIA CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 103Â AUSTRALIA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 104Â AUSTRALIA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 105Â SOUTH-EAST ASIA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 106Â SOUTH-EAST ASIA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 107Â SOUTH-EAST ASIA CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 108Â SOUTH-EAST ASIA CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 109Â SOUTH-EAST ASIA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 110Â SOUTH-EAST ASIA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 111Â REST OF ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 112Â REST OF ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 113Â REST OF ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 114Â REST OF ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 115Â REST OF ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 116Â REST OF ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 117Â EUROPE CARDIOVASCULAR DEVICES MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 118Â EUROPE CARDIOVASCULAR DEVICES MARKET BY COUNTRY (THOUSAND UNITS) 2020-2029
TABLE 119Â EUROPE CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 120Â EUROPE CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 121Â EUROPE CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 122Â EUROPE CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 123Â EUROPE CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 124Â EUROPE CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 125Â GERMANY CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 126Â GERMANY CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 127Â GERMANY CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 128Â GERMANY CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 129Â GERMANY CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 130Â GERMANY CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 131Â UK CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 132Â UK CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 133Â UK CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 134Â UK CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 135Â UK CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 136Â UK CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 137Â FRANCE CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 138Â FRANCE CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 139Â FRANCE CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 140Â FRANCE CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 141Â FRANCE CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 142Â FRANCE CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 143Â ITALY CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 144Â ITALY CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 145Â ITALY CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 146Â ITALY CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 147Â ITALY CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 148Â ITALY CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 149Â SPAIN CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 150Â SPAIN CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 151Â SPAIN CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 152Â SPAIN CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 153Â SPAIN CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 154Â SPAIN CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 155Â RUSSIA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 156Â RUSSIA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 157Â RUSSIA CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 158Â RUSSIA CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 159Â RUSSIA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 160Â RUSSIA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 161Â REST OF EUROPE CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 162Â REST OF EUROPE CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 163Â REST OF EUROPE CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 164Â REST OF EUROPE CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 165Â REST OF EUROPE CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 166Â REST OF EUROPE CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 167Â MIDDLE EAST AND AFRICA CARDIOVASCULAR DEVICES MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 168Â MIDDLE EAST AND AFRICA CARDIOVASCULAR DEVICES MARKET BY COUNTRY (THOUSAND UNITS) 2020-2029
TABLE 169Â MIDDLE EAST AND AFRICA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 170Â MIDDLE EAST AND AFRICA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 171Â MIDDLE EAST AND AFRICA CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 172Â MIDDLE EAST AND AFRICA CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 173Â MIDDLE EAST AND AFRICA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 174Â MIDDLE EAST AND AFRICA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 175Â UAE CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 176Â UAE CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 177Â UAE CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 178Â UAE CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 179Â UAE CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 180Â UAE CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 181Â SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 182Â SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 183Â SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 184Â SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 185Â SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 186Â SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 187Â SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 188Â SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 189Â SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 190Â SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 191Â SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 192Â SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
TABLE 193Â REST OF MIDDLE EAST AND AFRICA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (USD BILLION) 2020-2029
TABLE 194Â REST OF MIDDLE EAST AND AFRICA CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE (THOUSAND UNITS) 2020-2029
TABLE 195Â REST OF MIDDLE EAST AND AFRICA CARDIOVASCULAR DEVICES MARKET BY END USER (USD BILLION) 2020-2029
TABLE 196Â REST OF MIDDLE EAST AND AFRICA CARDIOVASCULAR DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 197Â REST OF MIDDLE EAST AND AFRICA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 198 REST OF MIDDLE EAST AND AFRICA CARDIOVASCULAR DEVICES MARKET BY APPLICATION (THOUSAND UNITS) 2020-2029
LIST OF FIGURES
FIGURE 1 MARKET DYNAMICS
FIGURE 2 MARKET SEGMENTATION
FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4 DATA TRIANGULATION
FIGURE 5 BOTTOM-UP APPROACH
FIGURE 6 TOP-DOWN APPROACH
FIGURE 7 RESEARCH FLOW
FIGURE 8 GLOBAL CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE, USD BILLION, 2022-2029
FIGURE 9 GLOBAL CARDIOVASCULAR DEVICES MARKET BY APPLICATION, USD BILLION, 2022-2029
FIGURE 10 GLOBAL CARDIOVASCULAR DEVICES MARKET BY END USER, USD BILLION, 2022-2029
FIGURE 11 GLOBAL CARDIOVASCULAR DEVICES MARKET BY REGION, USD BILLION, 2022-2029
FIGURE 12 PORTER’S FIVE FORCES MODEL
FIGURE 13 GLOBAL CARDIOVASCULAR DEVICES MARKET BY DEVICE TYPE, USD BILLION, 2021
FIGURE 14 GLOBAL CARDIOVASCULAR DEVICES MARKET BY APPLICATION, USD BILLION, 2021
FIGURE 15 GLOBAL CARDIOVASCULAR DEVICES MARKET BY END USER, USD BILLION,2021
FIGURE 16 GLOBAL CARDIOVASCULAR DEVICES MARKET BY REGION, USD BILLION, 2021
FIGURE 17 MARKET SHARE ANALYSIS
FIGURE 18 MEDTRONIC PLC: COMPANY SNAPSHOT
FIGURE 19 ABBOTT LABORATORIES: COMPANY SNAPSHOT
FIGURE 20 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
FIGURE 21 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
FIGURE 22 JOHNSON & JOHNSON: COMPANY SNAPSHOT
FIGURE 23 TERUMO CORPORATION: COMPANY SNAPSHOT
FIGURE 24 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 25 LIVANOVA PLC: COMPANY SNAPSHOT
FIGURE 26 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT
FIGURE 27 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
FIGURE 28 TELEFLEX INCORPORATED: COMPANY SNAPSHOT
FAQ
The global cardiovascular devices market is projected to grow from USD 50.76 billion in 2020 to USD 99.75 billion by 2029, at a CAGR of 8.2% during the forecast period.
North America accounted for the largest market in the Cardiovascular Devices market. North America accounted for 40 % market share of the global market value.
Medtronic, Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Johnson & Johnson, Philips Healthcare, Siemens Healthineers, GE Healthcare, Biotronik, Terumo Corporation
The trend toward minimally invasive procedures creates opportunities for innovative devices that enable less invasive interventions, reducing patient discomfort, hospital stays, and recovery times. Expanding remote monitoring capabilities allows for real-time tracking of patients’ cardiovascular health, enabling timely interventions and reducing the need for in-person visits.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.